Evidence map›Paper›PMID 38720895›Full record

ArticleFrontiers in immunology2024

Comparative analysis of whole plant, flower and root extracts of

Divya Lairikyengbam, Bernhard Wetterauer, Michael Schmiech, Beate Jahraus, Henning Kirchgessner, Pille Wetterauer, Karina Berschneider, Verena Beier, Beate Niesler, Emre Balta and 1 more

Abstract readComparative Study
In one paragraph

Article in Frontiers in immunology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Divya LairikyengbamSection Molecular Immunology, Institute of Immunology, Heidelberg University Hospital, Heidelberg, Germany.
Bernhard WetterauerInstitute of Pharmacy and Molecular Biotechnology, Heidelberg University, Heidelberg, Germany.
Michael SchmiechInstitute of Experimental and Clinical Pharmacology, Toxicology and Pharmacology of Natural Products, University of Ulm, Ulm, Germany.
Beate JahrausSection Molecular Immunology, Institute of Immunology, Heidelberg University Hospital, Heidelberg, Germany.
Henning KirchgessnerSection Molecular Immunology, Institute of Immunology, Heidelberg University Hospital, Heidelberg, Germany.
Pille WetterauerInstitute of Pharmacy and Molecular Biotechnology, Heidelberg University, Heidelberg, Germany.
Karina BerschneiderSection Molecular Immunology, Institute of Immunology, Heidelberg University Hospital, Heidelberg, Germany.
Verena BeierSection Molecular Immunology, Institute of Immunology, Heidelberg University Hospital, Heidelberg, Germany.
Beate NieslerDepartment of Human Molecular Genetics, Heidelberg University Hospital, Heidelberg, Germany.
Emre BaltaSection Molecular Immunology, Institute of Immunology, Heidelberg University Hospital, Heidelberg, Germany.
Yvonne SamstagSection Molecular Immunology, Institute of Immunology, Heidelberg University Hospital, Heidelberg, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Chronic inflammation is a hallmark of chronic wounds and inflammatory skin diseases. Due to a hyperactive and prolonged inflammation triggered by proinflammatory immune cells, transitioning to the repair and healing phase is halted. T cells may exacerbate the proinflammatory milieu by secreting proinflammatory cytokines. Methods: Phytochemical analysis of the extracts was carried out by LC-MS/MS. Primary human T cells from peripheral blood (PBTs) were pretreated with aqueous or hydroethanolic chamomile extracts or pure compounds. Subsequently, the effects on intracellular ROS levels, SDF-1α induced T cell migration, T cell activation, proliferation, and cytokine production after TCR/CD3 and CD28 costimulation were determined. Gene expression profiling was performed using nCounter analysis, followed by ingenuity pathway analysis, and validation at protein levels. Results: The tested chamomile extracts and pure compounds differentially affected intracellular ROS levels, migration, and activation of T cells. Three out of five differently prepared extracts and two out of three pure compounds diminished T cell proliferation. In line with these findings, LC-MS/MS analysis revealed high heterogeneity of phytochemicals among the different extracts. nCounter based gene expression profiling identified several genes related to T cell functions associated with activation and differentiation to be downregulated. Most prominently, apigenin significantly reduced granzyme B induction and cytotoxic T cell activity. Conclusion: Our results demonstrate an anti-inflammatory effect of chamomile- derived products on primary human T cells. These findings provide molecular explanations for the observed anti-inflammatory action of chamomile and imply a broader use of chamomile extracts in T cell driven chronic inflammatory diseases such as chronic wounds and inflammatory skin diseases. Importantly, the mode of extract preparation needs to be considered as the resulting different phytochemicals can result in differential effects on T cells.

Indexed as

Anti-Inflammatory AgentsCytokinesFlowersLymphocyte ActivationMatricariaPlant ExtractsT-LymphocytesCell MovementCell ProliferationCells, CulturedHumansPlant RootsAnti-Inflammatory AgentsCytokinesPlant ExtractsapigeninchamazuleneChamomilla recutita L. extractsimmunomodulationinflammationLC-MS/MSprimary human T cellsα-bisabolol

Identifiers

PMID38720895
PMCPMC11077421

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.